248
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 1085-1093 | Received 28 Jun 2012, Accepted 31 Oct 2012, Published online: 14 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Taiki Ando, Yoshiyuki Abe, Yukari Endo, Kurisu Tada, Ken Yamaji & Naoto Tamura. (2019) Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease. Modern Rheumatology 29:4, pages 656-661.
Read now
Eri Sato, Eiichi Tanaka, Moeko Ochiai, Yoko Shimizu, Akiko Kobayashi, Kumi Shidara, Daisuke Hoshi, Naoki Sugimoto, Eisuke Inoue, Yohei Seto, Ayako Nakajima, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2015) Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012. Modern Rheumatology 25:3, pages 350-357.
Read now

Articles from other publishers (21)

Anji Xiong, Wenxuan Luo, Xiaoyu Tang, Yuzi Cao, Qilang Xiang, Ruiting Deng & Shiquan Shuai. (2023) Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 63, pages 152257.
Crossref
Kohei Miyake, Tetsuji Kawamura, Yasuharu Nakahara & Shin Sasaki. (2023) A single-center, person-month-based analysis of the risk of developing Pneumocystis pneumonia (PCP) in immunosuppressed non-HIV patients: Preventive effects of trimethoprim-sulfamethoxazole. Journal of Infection and Chemotherapy 29:12, pages 1097-1102.
Crossref
Simon Galmiche, Benjamin Thoreau, Stéphane Bretagne, Alexandre Alanio, André Paugam, Valérie Letscher-Bru, Sophie Cassaing, Jean-Pierre Gangneux, Hélène Guegan, Loïc Favennec, Alida Minoza, Florent Morio, Julie Bonhomme, Guillaume Desoubeaux, Odile Eloy, Lilia Hasseine, Milène Sasso, Laurence Millon, Anne-Pauline Bellanger, Philippe Poirier, Maxime Moniot, Taieb Chouaki, Antoine Huguenin, Frédéric Dalle, Bernard Bouteille, Muriel Nicolas, Nicole Desbois-Nogard, Marie-Elisabeth Bougnoux, François Danion, Vincent Poindron, Antoine Néel, Karine Boukris-Sitbon, Fanny Lanternier & Benjamin Terrier. (2023) Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network. RMD Open 9:3, pages e003281.
Crossref
Ting Xue, Xiaomei Kong & Liang Ma. (2023) Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection. Journal of Fungi 9:8, pages 812.
Crossref
Daniel Clemente Garulo, Esmeralda Núñez-Cuadros, Marisol Camacho Lovillo, Joan Calzada-Hernández, Sara Guillén Martín, Laura Fernández Silveira, María José Lirola Cruz, Alfredo Tagarro, Rosa María Alcobendas Rueda, Agustín López López, Miren Satrustegi Aritziturri & Cristina Calvo. (2023) Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis. European Journal of Pediatrics.
Crossref
Shunsuke Mori, Yukitaka Ueki, Tomoya Miyamura, Koji Ishii, Toshihiko Hidaka, Tamami Yoshitama, Kazuyoshi Nakamura & Yasuo Suenaga. (2023) Outcomes and risk factors for mortality in Pneumocystis pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study . Modern Rheumatology 33:4, pages 723-731.
Crossref
H. Dele Davies. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 674 678.e3 .
Yuichi Ishikawa, Kazuhisa Nakano, Kei Tokutsu, Hiroko Miyata, Yoshihisa Fujino, Shinya Matsuda & Yoshiya Tanaka. (2021) Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases. RMD Open 7:1, pages e001508.
Crossref
Amine Ghembaza, Mathieu Vautier, Patrice Cacoub, Valérie Pourcher & David Saadoun. (2020) Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases. Chest 158:6, pages 2323-2332.
Crossref
Sandra Rodríguez, Andrés Muñoz, Rosa-Helena Bustos & Diego Jaimes. (2020) Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 8:9, pages 303.
Crossref
Takahiro Kageyama, Shunsuke Furuta, Kei Ikeda, Shin-ichiro Kagami, Daisuke Kashiwakuma, Takao Sugiyama, Takeshi Umibe, Norihiko Watanabe, Mieko Yamagata & Hiroshi Nakajima. (2019) Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases. PLOS ONE 14:3, pages e0214324.
Crossref
H. Dele Davies. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 651 656.e3 .
Fumikazu Sakai. 2018. Drug-Induced Lung Injury. Drug-Induced Lung Injury 59 81 .
Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani, Kazuyoshi Saito, Naoto Yokogawa, Kenji Nagasaka, Kenchi Takenaka, Makoto Soejima, Takahiko Sugihara, Hiroyuki Hagiyama, Shinya Hirata, Kazuo Matsui, Yoshinori Nonomura, Masahiro Kondo, Fumihito Suzuki, Makoto Tomita, Mari Kihara, Waka Yokoyama, Fumio Hirano, Hayato Yamazaki, Ryoko Sakai, Toshihiro Nanki, Ryuji Koike, Hitoshi Kohsaka, Nobuyuki Miyasaka & Masayoshi Harigai. (2017) Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial. Arthritis Research & Therapy 19:1.
Crossref
H. Dele Davies, Carrie L. Byington, Yvonne A. Maldonado, Elizabeth D. Barnett, Kathryn M. Edwards, Ruth Lynfield, Flor M. Munoz-Rivas, Dawn L. Nolt, Ann-Christine Nyquist, Mobeen H. Rathore, Mark H. Sawyer, William J. Steinbach, Tina Q. Tan & Theoklis E. Zaoutis. (2016) Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children. Pediatrics 138:2.
Crossref
MICHI TANAKA, RYOKO SAKAI, RYUJI KOIKE & MASAYOSHI HARIGAI. (2015) Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents . The Journal of Rheumatology 42:9, pages 1726.3-1728.
Crossref
Noboru Takayanagi,. (2015) Biological agents and respiratory infections: Causative mechanisms and practice management. Respiratory Investigation 53:5, pages 185-200.
Crossref
Despoina Papadopoulou, Christos Tsoulas, Athanassios Tragiannidis & Nikolaos V. Sipsas. (2015) Role of vaccinations and prophylaxis in rheumatic diseases. Best Practice & Research Clinical Rheumatology 29:2, pages 306-318.
Crossref
. (2015) Adalimumab. Reactions Weekly 1548:1, pages 13-13.
Crossref
Shunsuke MoriMineharu Sugimoto. (2015) Pneumocystis Jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations . Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23286.
Crossref
Takayuki Katsuyama, Kazuyoshi Saito, Satoshi Kubo, Masao Nawata & Yoshiya Tanaka. (2014) Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study. Arthritis Research & Therapy 16:1, pages R43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.